Skip to content

Cognitive bladder training versus rectal wash-out training for girls with dysfunctional voiding and constipation.

Cognitive bladder training versus rectal wash-out training for girls with dysfunctional voiding and constipation.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26475
Enrollment
120
Registered
2008-01-15
Start date
2008-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Dysfunctional voiding

Interventions

1. Cognitive bladder training
2. Rectal wash-out training. ad 1. the children will receive antibiotic medication, oral laxatives and training by a urotherapist. This consists of outpatient visits for elaborate instruction about v

Sponsors

University Medical Center Utrecht, Wilhelmina Kinderziekenhuis, Pediatric Renal Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female gender; 2. age between 6 and 12 years; 3. Non-Neurogenic Bladder/Sphincter Dysfunction (NNBSD) with recurrent Urinary Tract Infections (UTI) and constipation as shown by clinical evaluation, urodynamics, and ultrasound; 4. with or without urinary incontinence.

Exclusion criteria

Exclusion criteria: Congenital anomalies of the lower urinary tract except for vesico-ureteral reflux; and previous surgery of the urinary tracts except for surgery concerning vesico-ureteral reflux and correction of meatal stenosis.

Design outcomes

Primary

MeasureTime frame
The primary outcome parameter of the study is the absence of urinary tract infections. This is defined as having had no urinary tract infections in the last 6 months of study observation.

Secondary

MeasureTime frame
Secondary outcome measures are: absence of urinary incontinence in the last 6 months of study observation and recovery of the normal rectal sensation.

Contacts

Public ContactMarc A. Benninga

Kinderarts MDL, AMC, H7-248 P.O. Box 22660

m.a.benninga@amc.nl+31 (0)20 5663053 / +31 (0)20 5666297

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)